Todd Young compensation by year
ACADIA PHARMACEUTICALS Summary Compensation Table · all 3 fiscal years held| Component | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Salary | $147,462 | $409,542 | $350,568 |
| Bonus | $61,381 | $0 | $0 |
| Stock awards | $0 | $0 | $99,761 |
| Option awards | $4,287,440 | $2,675,273 | $973,878 |
| Non-equity incentive | $0 | $201,572 | $0 |
| All other | $200,260 | $15,232 | $61,887 |
| Total | $4,696,543 | $3,301,619 | $1,386,333 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ACADIA PHARMACEUTICALS INC DEF 14A filed April 30, 2019, accession 0001193125-19-129723, and prior-year filings. Open the filing on EDGAR.
How this page was built: the ACADIA PHARMACEUTICALS INC filed document, accession 0001193125-19-129723. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2019.
ACADIA PHARMACEUTICALS’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Stephen Davis | Chief Executive Officer | $6,508,032 |
| Srdjan Stankovic | President | $5,678,381 |
| Michael Yang | Former Executive Vice President, Chief Commercial Officer | $3,182,910 |
| Austin Kim | Executive Vice President, General Counsel, and Secretary | $2,126,212 |
| Todd Young · this page | Former Executive Vice President, Chief Financial Officer | $1,386,333 |
The full ACADIA PHARMACEUTICALS compensation record
free company briefThis page is one person within ACADIA PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the ACADIA PHARMACEUTICALS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ACADIA PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.